FDA enhances oversight of postmarket drug safety

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2012年 / 1400卷 / 1期

关键词：

Public Communication; Safety Communication; Safety Programme; Comprehensive Plan; Scientific Tool;

D O I：

10.2165/00128415-201214000-00003

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：2 / 2

相关论文

共 50 条

[41] FDA MAY PREEMPT DRUG SAFETY TESTING
不详
[J]. MATERIALS RESEARCH AND STANDARDS, 1972, 12 (08): : 34 - &
[42] FDA alerts asthmatics to drug safety risk
Ellis, C
[J]. NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (10) : 765 - 765
[43] FDA proposes changes to ensure drug safety
Wechsler, Jill
[J]. FORMULARY, 2007, 42 (03) : 205 - 206
[44] The FDA and drug safety - A proposal for sweeping changes
Furberg, Curt D.
Levin, Arthur A.
Gross, Peter A.
Shapiro, Robyn S.
Strom, Brian L.
[J]. ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (18) : 1938 - 1942
[45] Fda realigns drug inspection and manufacturing oversight operational changes at FDA and CDER aim to improve global market monitoring
Wechsler, Jill
[J]. 1600, Advanstar Communications Inc. (38): : 16 - 17
[46] FDA alerts asthmatics to drug safety risk
Clare Ellis
[J]. Nature Reviews Drug Discovery, 2003, 2 : 765 - 765
[47] FDA's role in drug safety.
Graham, D.
[J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2007, 165 (11) : S93 - S93
[48] Report criticizes lack of FDA oversight
Mitka, Mike
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (08): : 920 - 922
[49] Expansion of FDA oversight power sought
不详
[J]. ISSUES IN SCIENCE AND TECHNOLOGY, 2008, 24 (02) : 17 - 18
[50] GAO: FDA Oversight of Produce Is Poor
Kuehn, Bridget M.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (18): : 2106 - 2107

← 1 2 3 4 5 →